Advertisement

Topics

mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.

2016-09-25 21:49:08 | BioPortfolio

Published on BioPortfolio: 2016-09-25T21:49:08-0400

Clinical Trials [2582 Associated Clinical Trials listed on BioPortfolio]

Mobile Cardiovascular Risk Service Trial

Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as ...

Leveraging mHealth Messaging to Promote Adherence in Teens With CKD

The overall goal of this study is to develop and test effectively framed mobile health (mHealth) messages to promote medication adherence in teens with chronic kidney disease (CKD).

Primary Care Audit of Global Risk Management

1. Assessing the perception of Canadian Primary Care Physicians towards global cardiovascular risk assessment. 2. Correlating physician perceptions to actual practice data, gathere...

Neighborhood Environments and Cardiovascular Disease

To investigate the contributions of neighborhood environments to the distribution of cardiovascular disease (CVD) risk across different age ranges and racial/ethnic groups, using data from...

NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health

The purpose of the study is to investigate the preservation or promotion of health in students during the college years.

PubMed Articles [32538 Associated PubMed Articles listed on BioPortfolio]

Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients in Qatar.

Individuals who suffer from major cardiovascular events every year have one or more risk factors. Cardiovascular disease (CVD) risk assessment is an important strategy for the early identification of ...

Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.

Chronic kidney disease (CKD) is a global health burden and is independently associated with increased cardiovascular disease risk. Assessment of cardiovascular risk in the general population using pro...

Rheumatoid arthritis and risk of cardiovascular disease.

In developing countries, rheumatoid arthritis (RA) remains a seriously under-prioritised disease, particularly among the underprivileged, often resulting in presentation of patients late in the course...

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.

The updated national guidelines for cardiovascular risk assessment and lipid modification in the UK and US expand the indications for statin therapy in primary prevention to adults with moderate risk ...

Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?

To determine the accuracy of general practice recording of prior cardiovascular disease (CVD) at the time of CVD risk assessment and whether recording impacts on CVD management.

Medical and Biotech [MESH] Definitions

Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.

A specialty concerned with the nursing care of patients suffering from disorders of the CARDIOVASCULAR SYSTEM as well as those identified as at risk for adverse cardiac or vascular events.

The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.

A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.

More From BioPortfolio on "mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina."

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial